Research Diagnosis Related Groups (DRG) level LOS quality outcomes for AllianceHealth Midwest located at 2825 Parklawn Dr, Midwest City, OK, 73110 & includes data from NPIs 1093169377, 1043805732, 1730128836, 1417998691, 1700471497
Dexur analyzed Q3 2017 (July to September 2017) Medicare claims data to benchmark length of stay (LOS) outcomes for AllianceHealth Midwest compared to state, national and top peer hospitals at the Diagnosis Related Group (DRG) level.
| Total Hospitalizations (Jul 2017 to Sep 2017) | Total Hospitalizations After Exclusion | Total Users | Avg. LOS | Oklahoma Total Hospitalizations (Jul 2017 to Sep 2017) | Oklahoma Total Hospitalizations After Exclusion | Oklahoma Total Users | Oklahoma Avg. LOS | National Total Hospitalizations (Jul 2017 to Sep 2017) | National Total Hospitalizations After Exclusion | National Total Users | National Avg. LOS | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| All Inpatient | 809 | 754 | ||||||||||
| Surgical | 151 | 143 | ||||||||||
| Non Surgical | 658 | 611 | ||||||||||
| Cardiovascular | 131 | 118 | ||||||||||
| General Medicine | 115 | 105 | ||||||||||
| Psychiatry & Mental Disorders | 114 | 106 | ||||||||||
| Gastroenterology & Endocrinology | 82 | 81 | ||||||||||
| Pulmonology | 81 | 76 | ||||||||||
| Urology | 73 | 70 | ||||||||||
| Orthopedics | 69 | 65 | ||||||||||
| Neurology | 46 | 40 | ||||||||||
| General Surgery | 40 | 38 | ||||||||||
| Oncology & Hematology | 36 | 34 |
| Total Hospitalizations (Jul 2017 to Sep 2017) | Total Hospitalizations After Exclusion | Total Users | Avg. LOS | Oklahoma Total Hospitalizations (Jul 2017 to Sep 2017) | Oklahoma Total Hospitalizations After Exclusion | Oklahoma Total Users | Oklahoma Avg. LOS | National Total Hospitalizations (Jul 2017 to Sep 2017) | National Total Hospitalizations After Exclusion | National Total Users | National Avg. LOS | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Heart Failure And Shock | ||||||||||||
| DRG 291: HEART FAILURE AND SHOCK WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| Percutaneous Cardiovascular Procedures With Coronary Artery/Stent | ||||||||||||
| Acute Myocardial Infarction | ||||||||||||
| Cardiac Arrhythmia And Conduction Disorders |
| Total Hospitalizations (Jul 2017 to Sep 2017) | Total Hospitalizations After Exclusion | Total Users | Avg. LOS | Oklahoma Total Hospitalizations (Jul 2017 to Sep 2017) | Oklahoma Total Hospitalizations After Exclusion | Oklahoma Total Users | Oklahoma Avg. LOS | National Total Hospitalizations (Jul 2017 to Sep 2017) | National Total Hospitalizations After Exclusion | National Total Users | National Avg. LOS | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Septicemia Or Severe Sepsis | ||||||||||||
| DRG 871: SEPTICEMIA OR SEVERE SEPSIS WITHOUT MV >96 HOURS WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| Nutritional And Miscellaneous Metabolic Disorders | ||||||||||||
| DRG 641: MISCELLANEOUS DISORDERS OF NUTRITION, METABOLISM , FLUIDS AND ELECTROLYTES WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| Cellulitis | ||||||||||||
| DRG 603: CELLULITIS WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) |
| Total Hospitalizations (Jul 2017 to Sep 2017) | Total Hospitalizations After Exclusion | Total Users | Avg. LOS | Oklahoma Total Hospitalizations (Jul 2017 to Sep 2017) | Oklahoma Total Hospitalizations After Exclusion | Oklahoma Total Users | Oklahoma Avg. LOS | National Total Hospitalizations (Jul 2017 to Sep 2017) | National Total Hospitalizations After Exclusion | National Total Users | National Avg. LOS | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Psychoses | ||||||||||||
| DRG 885: PSYCHOSES | ||||||||||||
| Organic Disturbances And Intellectual Disability | ||||||||||||
| DRG 884: ORGANIC DISTURBANCES AND INTELLECTUAL DISABILITY |
| Total Hospitalizations (Jul 2017 to Sep 2017) | Total Hospitalizations After Exclusion | Total Users | Avg. LOS | Oklahoma Total Hospitalizations (Jul 2017 to Sep 2017) | Oklahoma Total Hospitalizations After Exclusion | Oklahoma Total Users | Oklahoma Avg. LOS | National Total Hospitalizations (Jul 2017 to Sep 2017) | National Total Hospitalizations After Exclusion | National Total Users | National Avg. LOS | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Esophagitis, Gastroenteritis And Miscellaneous Digestive Disorders | ||||||||||||
| DRG 392: ESOPHAGITIS, GASTROENTERITIS AND MISCELLANEOUS DIGESTIVE DISORDERS WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| G.I.Hemorrhage | ||||||||||||
| Diabetes |
| Total Hospitalizations (Jul 2017 to Sep 2017) | Total Hospitalizations After Exclusion | Total Users | Avg. LOS | Oklahoma Total Hospitalizations (Jul 2017 to Sep 2017) | Oklahoma Total Hospitalizations After Exclusion | Oklahoma Total Users | Oklahoma Avg. LOS | National Total Hospitalizations (Jul 2017 to Sep 2017) | National Total Hospitalizations After Exclusion | National Total Users | National Avg. LOS | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Chronic Obstructive Pulmonary Disease | ||||||||||||
| DRG 190: CHRONIC OBSTRUCTIVE PULMONARY DISEASE WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| Pulmonary Edema And Respiratory Failure | ||||||||||||
| DRG 189: PULMONARY EDEMA AND RESPIRATORY FAILURE | ||||||||||||
| Simple Pneumonia And Pleurisy |
| Total Hospitalizations (Jul 2017 to Sep 2017) | Total Hospitalizations After Exclusion | Total Users | Avg. LOS | Oklahoma Total Hospitalizations (Jul 2017 to Sep 2017) | Oklahoma Total Hospitalizations After Exclusion | Oklahoma Total Users | Oklahoma Avg. LOS | National Total Hospitalizations (Jul 2017 to Sep 2017) | National Total Hospitalizations After Exclusion | National Total Users | National Avg. LOS | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Renal Failure | ||||||||||||
| DRG 683: RENAL FAILURE WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||
| DRG 682: RENAL FAILURE WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| Kidney And Urinary Tract Infections | ||||||||||||
| DRG 690: KIDNEY AND URINARY TRACT INFECTIONS WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) |
| Total Hospitalizations (Jul 2017 to Sep 2017) | Total Hospitalizations After Exclusion | Total Users | Avg. LOS | Oklahoma Total Hospitalizations (Jul 2017 to Sep 2017) | Oklahoma Total Hospitalizations After Exclusion | Oklahoma Total Users | Oklahoma Avg. LOS | National Total Hospitalizations (Jul 2017 to Sep 2017) | National Total Hospitalizations After Exclusion | National Total Users | National Avg. LOS | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Major Hip And Knee Joint Replacement Or Reattachment Of Lower Extremity | ||||||||||||
| DRG 470: MAJOR JOINT REPLACEMENT OR REATTACHMENT OF LOWER EXTREMITY WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| Hip And Femur Procedures Except Major Joint |
| Total Hospitalizations (Jul 2017 to Sep 2017) | Total Hospitalizations After Exclusion | Total Users | Avg. LOS | Oklahoma Total Hospitalizations (Jul 2017 to Sep 2017) | Oklahoma Total Hospitalizations After Exclusion | Oklahoma Total Users | Oklahoma Avg. LOS | National Total Hospitalizations (Jul 2017 to Sep 2017) | National Total Hospitalizations After Exclusion | National Total Users | National Avg. LOS | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Intracranial Hemorrhage Or Cerebral Infarction | ||||||||||||
| DRG 064: INTRACRANIAL HEMORRHAGE OR CEREBRAL INFARCTION WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) |
| Total Hospitalizations (Jul 2017 to Sep 2017) | Total Hospitalizations After Exclusion | Total Users | Avg. LOS | Oklahoma Total Hospitalizations (Jul 2017 to Sep 2017) | Oklahoma Total Hospitalizations After Exclusion | Oklahoma Total Users | Oklahoma Avg. LOS | National Total Hospitalizations (Jul 2017 to Sep 2017) | National Total Hospitalizations After Exclusion | National Total Users | National Avg. LOS | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Red Blood Cell Disorders |